stockmarket

Boehringer Ingelheim plans to cut about 300 jobs in France


© Reuters. Boehringer Ingelheim plans to cut about 300 jobs in France

PARIS (Reuters) – German drugmaker Boehringer Ingelheim told unions on Monday that it plans to cut some 300 jobs in France as part of efforts to reorganise activities around its hub in Lyon following an asset swap with Sanofi (PA:) in 2017.

Unlisted Boehringer agreed in January last year to trade its consumer health division in exchange for France’s Sanofi animal health arm Merial in a $20 billion transaction.

Boehringer Ingelheim’s chairman for France, Jean Scheftsik de Szolnok, told Reuters the company was planning to cut up to 327 jobs out of a 2,800 workforce in France. However, it will also create 32 new positions.

He said the plan was to offer voluntary departure packages to avoid forced exits, but added that it was too early to give a timeframe.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.